| 0 (0%) | 11-11 21:05 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.41  |
1-year : | 0.65 |
| Resists | First : | 0.35 |
Second : | 0.55 |
| Pivot price | 0.02 |
|||
| Supports | First : | 0.01 | Second : | 0.01 |
| MAs | MA(5) : | 0.01 |
MA(20) : | 0.03 |
| MA(100) : | 0.48 |
MA(250) : | 0.58 |
|
| MACD | MACD : | -0.1  |
Signal : | -0.2 |
| %K %D | K(14,3) : | 14.9 |
D(3) : | 10.3 |
| RSI | RSI(14): 20.6 |
|||
| 52-week | High : | 1.35 | Low : | 0.01 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ VBIV ] has closed above bottom band by 27.4%. Bollinger Bands are 94.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.02 - 0.02 | 0.02 - 0.02 |
| Low: | 0.02 - 0.02 | 0.02 - 0.02 |
| Close: | 0.02 - 0.02 | 0.02 - 0.02 |
Tue, 19 Nov 2024
VBI recalls PreHevbrio and winds down operations - The Pharma Letter
Tue, 06 Aug 2024
Why Is VBI Vaccines (VBIV) Stock Up 62% Today? - InvestorPlace
Fri, 02 Aug 2024
VBIV stock touches 52-week low at $0.11 amid sharp decline - Investing.com
Fri, 02 Aug 2024
VBI Vaccines to be delisted from Nasdaq following restructuring - Investing.com
Fri, 02 Aug 2024
VBI Vaccines Provides an Update on its Restructuring Proceedings - Stock Titan
Tue, 30 Jul 2024
VBI Vaccines secures court protection as it restructures, seeks buyer(s) - Fierce Biotech
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 29 (M) |
| Shares Float | 27 (M) |
| Held by Insiders | 6.7 (%) |
| Held by Institutions | 13 (%) |
| Shares Short | 277 (K) |
| Shares Short P.Month | 275 (K) |
| EPS | -3.54 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.22 |
| Profit Margin | 0 % |
| Operating Margin | -968.1 % |
| Return on Assets (ttm) | -29.2 % |
| Return on Equity (ttm) | -419.6 % |
| Qtrly Rev. Growth | 150.3 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0.32 |
| EBITDA (p.s.) | -1.59 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -51 (M) |
| Levered Free Cash Flow | -29 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | -0.09 |
| Price to Sales | 0.05 |
| Price to Cash Flow | -0.02 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|